"Allyl Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Alkenes with the general formula H2C=CH-CH2-R.
Descriptor ID |
D000498
|
MeSH Number(s) |
D02.455.326.271.122
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Allyl Compounds".
Below are MeSH descriptors whose meaning is more specific than "Allyl Compounds".
This graph shows the total number of publications written about "Allyl Compounds" by people in this website by year, and whether "Allyl Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2014 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Allyl Compounds" by people in Profiles.
-
Diallyl disulfide inhibits TGF-?1-induced upregulation of Rac1 and ?-catenin in epithelial-mesenchymal transition and tumor growth of gastric cancer. Oncol Rep. 2018 Jun; 39(6):2797-2806.
-
Identification of potential targets for differentiation in human leukemia cells induced by diallyl disulfide. Int J Oncol. 2017 Feb; 50(2):697-707.
-
Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer. Oncotarget. 2016 Mar 01; 7(9):10498-512.
-
Diallyl disulfide selectively causes checkpoint kinase-1 mediated G2/M arrest in human MGC803 gastric cancer cell line. Oncol Rep. 2014 Nov; 32(5):2274-82.
-
A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growth. Clin Cancer Res. 2013 Aug 15; 19(16):4455-64.
-
Perturbation of dopamine metabolism by 3-amino-2-(4'-halophenyl)propenes leads to increased oxidative stress and apoptotic SH-SY5Y cell death. Mol Pharmacol. 2007 Sep; 72(3):744-52.